MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures

Go back to MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
MACROGENICS (NASDAQ: MGNX) Delayed: 4.00 +0.03 (0.76%)
Previous Close $3.97    52 Week High $36.11 
Open $4.02    52 Week Low $14.84 
Day High $4.09    P/E 10.26 
Day Low $3.91    EPS $0.39 
Volume 381,930